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Abstract
Introduction: It is known that fibrous particles of micrometer length, such as carbon nanotubes, which have same
dimensions as asbestos, are carcinogenic. Carcinogenicity of nanomaterials is strongly related to inflammatory
reactions; however, the genotoxicity mechanism(s) is unclear. Indeed, inconsistent results on genotoxicity of multi-
walled carbon nanotubes (MWCNTs) have been shown in several reports. Therefore, we analyzed the in vivo
genotoxicity induced by an intratracheal instillation of straight MWCNTs in rats using a different test system—the
Pig-a gene mutation assay—that can reflect the genotoxicity occurring in the bone marrow. Since lungs were
directly exposed to MWCNTs upon intratracheal instillation, we also performed the gpt assay using the lungs.
Findings: We detected no significant differences in Pig-a mutant frequencies (MFs) between the MWCNT-treated
and control rats. Additionally, we detected no significant differences in gpt MFs in the lung between the MWCNT-
treated and control rats.
Conclusions: Our findings indicated that a single intratracheal instillation of MWCNTs was non-mutagenic to both
the bone marrow and lung of rats.
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Introduction
Nanomaterials are important substances in nanotechnol-
ogy, and potential risks to humans and the environment
need to be investigated for risk assessment and manage-
ment. There are several reports on the toxicities induced
by carbon nanoparticles, such as fullerene (C60), single-
walled carbon nanotubes, and multi-walled carbon
nanotubes (MWCNTs). It is known that fibrous or rod-
shaped particles of micrometer length, which share the
dimensions with asbestos, are carcinogenic to humans
and experimental animals [1–5]. The carcinogenicity
and toxicity induced by exposure to nanomaterials are
strongly related to inflammatory reactions and reactive
oxygen species [6–10]. In particular, mesothelioma was
induced by intraperitoneal application of MWCNTs in
p53+/− mice [4] and by intrascrotal administration of
MWCNTs to wild-type rats [5]. Additionally, malignant
mesothelioma and lung tumors were induced by admin-
istration of MWCNT to the lung via the trans-tracheal
intrapulmonary spraying method [11]. However, the
genotoxicity mechanism(s) related to carcinogenesis in-
duced by MWCNT treatment is unclear.
There are several reports on the in vivo genotoxicity
of MWCNTs, but they provide conflicting data [12–15].
In vivo comet assay revealed that a single intratracheal
or pharyngeal instillation of MWCNTs to mice both in-
duced DNA damage in the lungs in a dose-dependent
manner [13, 15]. However, another group reported that
MWCNTs administered by gavage showed no genotoxic
effect in an in vivo micronucleus test [12]. Additionally,
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an intratracheal instillation of MWCNTs to rats was also
non-genotoxic, as demonstrated by the comet assay of
the lung [14]. Using a different endpoint, it was reported
that an intratracheal instillation of MWCNTs in mice
increased the mutation frequency detected by the gpt
assay in the lung [13].
These discrepancies prompted us to examine in vivo
mutagenicity in the lung, induced by an intratracheal in-
stillation of MWCNTs, using gpt-delta transgenic rats
because the lung was directly exposed to MWCNTs
under our experimental conditions. The gpt assay is
known as one of the gene mutation assays using a trans-
genic rodent. Additionally, we employed a different test
system, the recently established Pig-a gene mutation assay
[16–19]. This is a powerful tool for the evaluation of in
vivo genotoxicity and is based on flow cytometric enu-
meration of glycosylphosphatidylinositol (GPI) anchor-
deficient erythrocytes [16, 17]. It is applicable across spe-
cies, from rodents to humans [20–24]. For this method, no
transgenic animals are needed to test in vivo genotoxi-
city; all that is needed is a small volume of peripheral
blood [16, 17]. Additionally, long-term, accumulated




F344/NSlc-Tg (gpt-delta) male rats were obtained from
Japan SLC (Shizuoka, Japan). The animals were housed
individually under specific pathogen-free conditions with
a 12-h light–dark cycle. Food (CRF-1 pellet feed, Oriental
Yeast Co., Ltd., Tokyo, Japan) and water were available ad
libitum. Animal experiments were conducted in accord-
ance with the regulations of the Animal Care and Use
Committees of the National Institute of Health Sciences
and Tokyo Metropolitan Institute of Public Health.
Test chemicals
MWCNTs (Lot No. 060125-01 k, Mitsui & Co., Ltd.,
Ibaraki, Japan) were prepared as described previously
[4, 5, 26], with some modifications. According to the
reports, these straight MWCNT fibers are approxi-
mately 100 nm in diameter, and 27.5% of the
MWCNTs are ≥ 5 μm in length. The MWCNTs were
suspended in a 0.2% (w/v) carboxymethyl cellulose
(CMC) solution (Kanto Chemical Co., Ltd., Tokyo,
Japan). The suspensions and the vehicle (0.2% CMC
solution) were sterilized in an autoclave at 120 °C for
20 min and vigorously mixed by hand shaking imme-
diately prior to the administration [5]. N-nitroso-N-
ethylurea (ENU, Sigma) was dissolved in phosphate-
buffered saline (pH 6.0) at 10 mg/mL as described
previously [18].
Antibodies
We obtained anti-rat CD59 [clone TH9, fluorescein iso-
thiocyanate (FITC)-conjugated] and anti-rat erythroid
marker (clone HIS49, allophycocyanin-conjugated) anti-
bodies from BD Biosciences (Tokyo, Japan).
Dose levels and treatments
At eight weeks of age, six male rats per group received a
single intratracheal treatment of MWCNTs (0.25, 0.5, or
1 mg/kg) or the vehicle (negative control). The intratra-
cheal spraying injection was performed using a micro-
sprayer (series IA-1B intratracheal aerosolizer; Penn-
Century, Philadelphia, PA, USA) as described previously
[27]. ENU (35.6 mg/kg) was administered intraperitone-
ally to six male rats for the positive control. Additionally,
six male rats were treated with MWCNTs (intratrache-
ally, 1 mg/kg) plus ENU (intraperitoneally, 35.6 mg/kg).
At four weeks after the administration, all rats were
sacrificed, and blood and lung samples were collected
for the Pig-a and gpt assays, respectively. Because of the
high cost of the gpt assay, the lung samples of both the
control groups and highest dose group were analyzed
prior to the other groups. In the case where a negative
genotoxicity was detected in the highest dose group,
analyses of the other groups were discontinued.
Pig-a mutation assay
The Pig-a assay was performed as described previously
[28, 29]. Blood (3 μL) was labeled with anti-rat CD59
(1 μg) and anti-rat erythroid marker (0.133 μg) anti-
bodies. Approximately 1 × 106 erythroid marker-positive
cells were analyzed using a FACSCanto II flow cytometer
(BD Biosciences) for the presence of surface CD59, and
Pig-a mutant frequencies (MFs) were expressed as the
number of CD59-negative cells per one million of
HIS49-positive red blood cells (RBCs). To avoid artifac-
tually inflating Pig-a MFs, we refined the gate for Pig-a
mutant RBCs as the area encompassing a maximum of
99.0% of the lower RBC FITC staining intensities only,
as previously described [28–31].
gpt mutation assay
High-molecular-weight genomic DNA was extracted from
the lung samples of the rats treated with MWCNTs
(1 mg/kg), the vehicle, and ENU using a Recover Ease
DNA isolation kit (Agilent Technologies, Santa Clara, CA,
USA). Lambda EG10 phages were rescued using the
Transpack packaging extract (Agilent Technologies), and
the gpt mutation assay was conducted as described previ-
ously [28, 32]. gpt MFs were calculated by dividing the
number of confirmed 6-thioguanine-resistant colonies by
the number of colonies with rescued plasmids [32].
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Calculations and statistical analyses
Statistical analyses were performed using Excel Statis-
tics 2012 (Social Survey Research Information, Tokyo,
Japan) as follows. Distributions were tested by the
Bartlett’s test. If the distributions were normal, one-
way analysis of variance was applied, followed by the
Dunnett’s post-hoc test (pairwise comparisons of the
frequencies in the treated groups to that in the vehicle
control group, one-sided). Otherwise, the Kruskal–
Wallis test was applied for analysis, followed by the
Steel’s post-hoc test (pairwise comparisons of the fre-




Compared with the control, the Pig-a MFs clearly in-
creased in the ENU- and ENU plus MWCNT-treated rats
(Fig. 1). In contrast, we detected no significant differences
in the Pig-a MFs among the MWCNT-only-treated
groups (Fig. 1). Additionally, we detected no significant
differences in the Pig-a MFs between the ENU- and ENU
plus MWCNT-treated rats (Fig. 1).
gpt assay
Compared with the control, the gpt MFs significantly
increased in the ENU-treated rats (Fig. 2 and Table 1).
In contrast, we detected no significant differences in the
gpt MFs in the lungs among the MWCNT-treated
groups (Fig. 2 and Table 1).
Fig. 1 Pig-a mutant frequencies. Four weeks after the treatments,
blood was withdrawn and analyzed by flow cytometry for the
presence of surface CD59 on RBCs. Each treated group is shown
under the bars. The data are the mean ± standard deviation (SD).
**p < 0.01 compared to the control
Fig. 2 gpt mutant frequencies in the lung. Four weeks after the
treatments, the rats were sacrificed, and their lung samples were
collected and analyzed by the gpt assay. Each treated group is
shown under the bars. The data are the mean ± SD. *p < 0.05
compared to the control
Table 1 Induction of mutations (gpt assay) in the lungs of








0.2% CMC* 0 1 756,000 5 6.61
2 1,284,000 2 1.56
3 924,000 0 0.00
4 720,000 0 0.00
5 939,000 1 1.06
6 621,000 0 0.00
Ave. 1.54
S.D. 2.57
MWCNT 1 1 1,035,000 2 1.93
2 810,000 4 4.94
3 930,000 0 0.00
4 909,000 2 2.20
5 951,000 1 1.05
6 870,000 1 1.15
Ave. 1.88
S.D. 1.69
ENU 35.6 1 777,000 1 1.29
2 894,000 4 4.47
3 744,000 3 4.03
4 510,000 1 1.96
5 567,000 6 10.58
6 678,000 2 2.95
Ave. 4.21**
S.D. 3.34
*CMC, a carboxymethyl cellulose solution (negative control)
**p < 0.05 compared to the control
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Discussion
It has been reported that aspiration exposure of mice to
MWCNTs induced strong inflammatory reactions [33],
and an intratracheal instillation of MWCNTs to rats
resulted in strong pulmonary toxicity effects, including
focal peribronchiolar lymphoid aggregates, foamy alveolar
macrophage accumulation, lymphoplasmocytic infiltra-
tion, fibrosis, and diffuse alveolar damage [34]. Inflamma-
tory reactions induced by MWCNTs treatment seem to
be the cause of genotoxicity [13].
An in vivo comet assay revealed that a single intra-
tracheal instillation of MWCNTs to mice induced
DNA damage in the lungs in a dose-dependent man-
ner. Oxidative DNA damage related to inflammation
was also detected in mouse lungs [13]. Additionally,
the in vivo comet assay using mouse lungs revealed
that single pharyngeal aspiration of straight MWCNTs,
but not tangled MWCNTs, induced DNA damage in a
dose-dependent manner [15]. However, oral administra-
tion of MWCNTs to mice showed no genotoxicity in the
erythrocyte micronucleus test [12]. Both single and re-
peated doses of intratracheally instilled MWCNTs were
found by comet assays to be non-genotoxic to rat lung
cells, although inflammatory changes, including infiltra-
tion of macrophages and neutrophils, were detected in the
rats [14]. In the above reports, in vivo genotoxicity of
MWCNTs was evaluated by direct detection of DNA
damage, e.g., using the comet assay and micronucleus test.
However, the results were inconsistent. To elucidate the
in vivo genotoxicity potential of MWCNTs, we employed
different endpoints and evaluated in vivo genotoxicity of
MWCNTs using two gene mutation assays, i.e., the Pig-a
and gpt assays.
We demonstrated that straight MWCNTs adminis-
tered intratracheally to male F344/NSlc-Tg (gpt-delta)
rats were negative for genotoxicity in the Pig-a assay
using blood (Fig. 1). The Pig-a assay is based on the
detection of a GPI-anchored protein on the cell surface
of RBCs. It is considered that the absence of the GPI-
anchored protein in RBCs is caused by mutations in the
Pig-a gene, occurring in nucleated erythroid precursors
and/or in hematopoietic stem cells (HSCs) [16, 19]. This
suggests that the expression of GPI-anchored CD59 in
RBCs depends on the Pig-a mutations that occurred in
erythroid precursors and/or HSCs in the bone marrow.
According to this, we considered that our results ob-
tained by the Pig-a assay reflected the genotoxicity of
MWCNTs to the bone marrow. We also detected no
significant difference in the Pig-a MFs between the
groups treated with ENU alone or with ENU plus
MWCNTs. This result indicated that the treatment with
MWCNTs did not increase the ENU genotoxicity to the
bone marrow. Because the target organ was the lung in
our experiments, the negative results of the Pig-a assay
were not unexpected. On the other hand, MWCNTs were
non-genotoxic to the lungs as shown by the gpt assay,
although the lungs were directly exposed to MWCNTs
(Fig. 2). Based on these findings, we concluded that no
mutagenicity was induced by a single intratracheal treat-
ment with straight MWCNTs in both the lung and bone
marrow. Interestingly, similar results were shown by Kato
et al. [13]. In their report, the gpt assay revealed that no
genotoxicity was induced by a single- and two-times
repeated intratracheal instillation; however, a four-times
repeated treatment resulted in genotoxicity.
All these studies indicate that the nature of MWCNTs,
exposure conditions, method, route, and endpoints are
important when evaluating the genotoxicity of MWCNTs.
At this time, we cannot explain the mechanism(s) of
MWCNT genotoxicity in detail, but we suspect that the
mechanism(s) is complex and depends on the nature of
MWCNTs, oxidative DNA damages, inflammation, and
other biological factors, as previously discussed for an-
other nanomaterial, C60 [18].
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